TB
Telesis Bio, Inc.
TBIO · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $78.4K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.00x
P/B 0.00x
P/E N/A
Growth
100 /100
Growing Rev. growth 61.13%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 61.62%
Net margin 173.49%
FCF margin 133.22%
Quality
7 /100
Poor ROIC 72.70%
ROA 67.78%
Asset turnover 0.39x
Debt
44 /100
Moderate Debt/Equity 1.16x
Current ratio 3.71x
Int. coverage -14.36x
Stability
7 /100
Unstable Beta 2.47x
Rev. volatility 74.18%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TBIO
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Eric Esser
Employees
39
Headquarters
San Diego
Prihajajoči dogodki
17 NOV.
Earnings
Upcoming earnings report